Literature DB >> 31916454

Collagenase Use and a Trap for the Unwary in Patients With Upper Limb Spasticity.

Suzanne M Beecher1, Billy Lane O'Neill1, Michael O'Shaughnessy1.   

Abstract

Collagenase has revolutionized the treatment of Dupuytren's disease. It acts by lysing collagen in Dupuytren's cords. It can also act on collagen in tendons, leading to tendon rupture. In this letter, we highlight caution where bowstringed flexor tendons were masquerading as Dupuytren's cords in a patient with upper limb spasticity. The initial plan was to inject the cords with collagenase; however, we proceeded with an open approach. If we had proceeded with our initial plan to inject the palpable cords with collagenase, tendon rupture would have been the likely outcome. We advise that administrators of collagenase proceed with caution in patients with upper limb neurological disorders, bearing in mind that bow-stringed flexor tendons can mimic Dupuytren's cords.

Entities:  

Keywords:  bowstring; collagenase; dupuytren’s disease; flexor tendon; tendon rupture

Mesh:

Substances:

Year:  2020        PMID: 31916454      PMCID: PMC8647331          DOI: 10.1177/1558944719895781

Source DB:  PubMed          Journal:  Hand (N Y)        ISSN: 1558-9447


  4 in total

Review 1.  Nonoperative treatment of Dupuytren's disease.

Authors:  L C Hurst; M A Badalamente
Journal:  Hand Clin       Date:  1999-02       Impact factor: 1.907

2.  Flexor tendon rupture after collagenase injection for Dupuytren contracture: case report.

Authors:  Andrew Y Zhang; Catherine M Curtin; Vincent R Hentz
Journal:  J Hand Surg Am       Date:  2011-06-25       Impact factor: 2.230

3.  Collagen as a clinical target: nonoperative treatment of Dupuytren's disease.

Authors:  Marie A Badalamente; Lawrence C Hurst; Vincent R Hentz
Journal:  J Hand Surg Am       Date:  2002-09       Impact factor: 2.230

4.  Injectable collagenase clostridium histolyticum for Dupuytren's contracture.

Authors:  Lawrence C Hurst; Marie A Badalamente; Vincent R Hentz; Robert N Hotchkiss; F Thomas D Kaplan; Roy A Meals; Theodore M Smith; John Rodzvilla
Journal:  N Engl J Med       Date:  2009-09-03       Impact factor: 91.245

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.